Pfizer (PFE) Revenue — Quarter Ended Jul 2, 2023
Revenue declined sharply compared to both the prior quarter and the same period a year ago. The drop extends a pattern of year-over-year contraction seen in recent quarters.
Key takeaway
Quarter ended Jul 2, 2023 · FY2023 Q2
Revenue declined sharply compared to both the prior quarter and the same period a year ago. The drop extends a pattern of year-over-year contraction seen in recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$13B
Revenue reported for this quarter.
Quarter-over-quarter
-29.6%
Change from the immediately preceding quarter.
Year-over-year
-53.1%
Change from the comparable year-ago quarter.
Trailing four quarters
$79.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Oct 2, 2022 | $22.6B | -5.8% |
| Dec 31, 2022 | $25.1B | +55.3% |
| Apr 2, 2023 | $18.5B | -28.0% |
| Jul 2, 2023 | $13B | -53.1% |
Revenue performance
Reported revenue fell, reflecting a continuation of the downward trajectory from the previous quarter. The decline was substantial on a year-over-year basis.
Quarterly comparison
Revenue was lower than the immediately preceding quarter and was significantly below the level reported in the same quarter one year earlier.
What to watch
Monitor whether revenue can stabilize after several quarters of sequential and year-over-year declines.